CG MedTech Co.,Ltd. (KOSDAQ:056090)
South Korea · Delayed Price · Currency is KRW 4,550.00
-130.00 (-2.78%)
At close: Oct 23, 2026
CG MedTech Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 51,199 | 47,235 | 34,623 | 34,969 | 41,169 | 38,055 |
Revenue Growth | 19.80% | 36.43% | -0.99% | -15.06% | 8.18% | 37.01% |
Gross Profit Gross Profit Growth | 21,049 | 20,863 | 15,789 | 17,829 | 18,651 | 15,484 |
Operating Income Operating Income Growth | 1,876 | 3,802 | -1,096 | 2,204 | -10,177 | -815.21 |
Net Income Net Income Growth | 6,554 | 6,508 | 59.69 | 1,629 | -18,540 | -4,970 |
Earnings Per Share EPS Growth | 320.13 | 315.00 | 3.18 | 103.26 | -1395.00 | -560.00 |
EPS Growth | 209.55% | 9804.07% | -96.92% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Devices Medical Devices Growth | 47,434 | 39,588 | 28,339 | 28,868 | 26,314 | 25,025 |
Electric Energy Electric Energy Growth | 11,933 | 12,973 | 10,174 | 9,345 | 17,193 | 14,943 |
Adjustment and Removal Adjustment and Removal Growth | -8,168 | -5,326 | -3,890 | -3,245 | -2,338 | -1,913 |
Total Total Growth | 51,199 | 47,235 | 34,623 | 34,969 | 41,169 | 38,055 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 10,752 | 10,844 | 34,299 | 14,348 | 74,987 | 20,187 |
Total Debt Total Debt Growth | 20,512 | 4,309 | 4,431 | 4,367 | 66,009 | 29,975 |
Net Cash (Debt) Net Cash Growth | -9,759 | 6,535 | 29,867 | 9,981 | 8,977 | -9,788 |
Net Cash Growth | - | -78.12% | 199.24% | 11.18% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -476.89 | 316.46 | 1591.40 | 632.68 | 674.63 | -1099.39 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -1,914 | 2,613 | 1,511 | -2,478 | -5,365 | 1,237 |
Capital Expenditures CapEx Growth | -20,863 | -11,479 | -773.97 | -1,590 | -819.5 | -862.16 |
Free Cash Flow Free Cash Flow Growth | -22,777 | -8,866 | 736.7 | -4,068 | -6,184 | 375.08 |
Free Cash Flow Growth | - | - | - | - | - | -80.72% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.11% | 44.17% | 45.60% | 50.99% | 45.30% | 40.69% |
Operating Margin | 3.66% | 8.05% | -3.17% | 6.30% | -24.72% | -2.14% |
Pretax Margin | 5.36% | 5.79% | 0.04% | 3.97% | -44.75% | -14.20% |
Profit Margin | 12.80% | 13.78% | 0.17% | 4.66% | -45.03% | -13.06% |
FCF Margin | -44.49% | -18.77% | 2.13% | -11.63% | -15.02% | 0.99% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.21 | 18.53 | 1743.71 | 57.14 | - | - |
Forward PE | - | 26.54 | 26.54 | 26.54 | 26.54 | 26.54 |
P/FCF Ratio | - | - | 141.29 | - | - | 120.94 |
PS Ratio | 1.84 | 2.55 | 3.01 | 2.66 | 2.26 | 1.19 |